The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.
about
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive reviewSerotonin, neural markers, and memoryBehavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterDifferential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in micePharmacological treatments for methamphetamine addiction: current status and future directions.The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analoguesPerformance enhancement in the workplace: why and when healthy individuals should disclose their reliance on pharmaceutical cognitive enhancers.Psychostimulant addiction treatment.Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts.Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders.Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring ratsModafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in miceCortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals.A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.Acceleration of cardiovascular-biological age by amphetamine exposure is a power function of chronological age.Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.Drugs, games, and devices for enhancing cognition: implications for work and society.Modafinil enhances alerting-related brain activity in attention networks.Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial.Chronic methamphetamine self-administration disrupts cortical control of cognition.Dopamine Transporter Correlates and Occupancy by Modafinil in Cocaine-Dependent Patients: A Controlled Study With High-Resolution PET and [(11)C]-PE2IModafinil decreases anxiety-like behaviour in zebrafish.Modafinil decreases cocaine choice in human cocaine smokers only when the response requirement and the alternative reinforcer magnitude are large.Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors.The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons.The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.Modafinil Dependence: A Case with Attention-Deficit/Hyperactivity Disorder.Effects of circadian misalignment on sleep in mice
P2860
Q26749602-3EEE4BB7-76AD-42EB-BAA2-BF1046032C71Q26800204-24E5047F-790E-4323-A88E-253F303D0817Q26829749-EB770BB2-549E-41CD-A756-561E8E2EE20CQ28397225-EB7CC193-5CFF-45E0-86A5-604589309E1CQ30240173-AED19B55-303A-476B-8E3D-BBE82E12A070Q33598487-5ABBCA4B-1E52-4E4D-A017-DB22DC1C4E94Q34396818-0C5F4640-92F0-42ED-9A0A-EE0B70548817Q34402198-F85CF5FF-A4E1-4FE6-AE90-61CECD0C641EQ35120607-3C06C8E5-E8E4-496B-8386-D263F102A7E9Q35915231-723DB6D0-58B4-4A20-A9E3-54CF9515C41EQ35973078-088151A2-321B-41E6-937A-4D05390484CFQ36813681-0678481B-CF94-46AA-AFE6-310A4281DD6AQ36977149-D52B13FE-2524-4D49-B524-C092FD8F0E06Q37024852-BE6A0A34-D2C1-4122-AB28-3ECA0CC75212Q37229459-C3108A19-7A24-4DE7-964E-DD09E32C0094Q37606384-7A17645C-E9FE-4B33-B3CA-61F403BE9A10Q37621846-E30716C3-F391-4286-B6DC-AB2C2A0175BFQ37640278-92BC7BBF-D32B-43A6-AF47-FE25039A6230Q37671995-9E6CF897-3192-4F7B-B7B1-B5160FB88A1DQ38797653-5C2A911F-201C-4A6D-AC78-C837DD333331Q38857162-568AE254-8701-47F9-89AE-BEF2E548FB0EQ38871336-10CC564B-4C68-4F41-A9C8-490154E7A267Q38906406-A5A10C63-564A-4FDC-B1AF-788DE4691523Q41845653-51C768B4-27CA-4AB6-A824-D159858814D8Q42321073-8F1F7650-0967-4494-8C8D-98E2CD6BEA0AQ42841409-3A1EFE92-962E-4994-A5C2-761D74B22C2CQ46734392-4C84C304-1D20-499F-A2C3-BBDA835162A4Q47103759-2DBD496C-33EA-45D1-8F36-C015A8FC36F6Q47825128-9D20CC1D-953F-4A4F-82A9-3AF9418387CEQ48156370-8DED300F-C7E1-4297-B598-D3410405D159Q50023810-E67F2568-6D8B-4AE3-9AC7-B828966C1577Q52316982-E057C3DD-AA98-4D1B-AD34-2C0B6463CC9AQ58116190-B84A8D65-2D95-4CE5-B17B-26A3F5ED63EE
P2860
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The neurobiology of modafinil ...... t for substance use disorders.
@ast
The neurobiology of modafinil ...... t for substance use disorders.
@en
The neurobiology of modafinil ...... t for substance use disorders.
@nl
type
label
The neurobiology of modafinil ...... t for substance use disorders.
@ast
The neurobiology of modafinil ...... t for substance use disorders.
@en
The neurobiology of modafinil ...... t for substance use disorders.
@nl
prefLabel
The neurobiology of modafinil ...... t for substance use disorders.
@ast
The neurobiology of modafinil ...... t for substance use disorders.
@en
The neurobiology of modafinil ...... t for substance use disorders.
@nl
P2093
P2860
P1433
P1476
The neurobiology of modafinil ...... t for substance use disorders.
@en
P2093
Antonello Bonci
Gianluigi Tanda
Maddalena Mereu
P2860
P2888
P304
P356
10.1007/S00213-013-3232-4
P577
2013-08-10T00:00:00Z
P5875
P6179
1018595429